HEADER LYASE/LYASE INHIBITOR 14-JAN-20 6VJ3 TITLE CARBONIC ANHYDRASE II IN COMPLEX WITH PYRIMIDINE-BASED INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARBONIC ANHYDRASE 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CARBONATE DEHYDRATASE II,CARBONIC ANHYDRASE C,CAC,CARBONIC COMPND 5 ANHYDRASE II,CA-II; COMPND 6 EC: 4.2.1.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CA2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CA II, SULFONAMIDE, PYRIMIDINE, INHIBITOR, CANCER, LYASE, LYASE-LYASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.L.LOMELINO,R.MCKENNA REVDAT 2 11-OCT-23 6VJ3 1 REMARK REVDAT 1 11-MAR-20 6VJ3 0 JRNL AUTH A.PETRENI,A.BONARDI,C.LOMELINO,S.M.OSMAN,Z.A.ALOTHMAN, JRNL AUTH 2 W.M.ELDEHNA,R.EL-HAGGAR,R.MCKENNA,A.NOCENTINI,C.T.SUPURAN JRNL TITL INCLUSION OF A 5-FLUOROURACIL MOIETY IN NITROGENOUS BASES JRNL TITL 2 DERIVATIVES AS HUMAN CARBONIC ANHYDRASE IX AND XII JRNL TITL 3 INHIBITORS PRODUCED A TARGETED ACTION AGAINST MDA-MB-231 AND JRNL TITL 4 T47D BREAST CANCER CELLS. JRNL REF EUR.J.MED.CHEM. V. 190 12112 2020 JRNL REFN ISSN 0223-5234 JRNL PMID 32044580 JRNL DOI 10.1016/J.EJMECH.2020.112112 REMARK 2 REMARK 2 RESOLUTION. 1.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.15 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 52759 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.152 REMARK 3 R VALUE (WORKING SET) : 0.151 REMARK 3 FREE R VALUE : 0.173 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2586 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.1460 - 3.5376 0.99 2919 148 0.1372 0.1534 REMARK 3 2 3.5376 - 2.8084 1.00 2876 144 0.1442 0.1727 REMARK 3 3 2.8084 - 2.4536 1.00 2830 159 0.1470 0.1417 REMARK 3 4 2.4536 - 2.2293 1.00 2857 128 0.1361 0.1789 REMARK 3 5 2.2293 - 2.0695 1.00 2834 126 0.1323 0.1626 REMARK 3 6 2.0695 - 1.9475 1.00 2803 163 0.1384 0.1593 REMARK 3 7 1.9475 - 1.8500 1.00 2816 126 0.1393 0.1868 REMARK 3 8 1.8500 - 1.7695 1.00 2848 137 0.1465 0.1637 REMARK 3 9 1.7695 - 1.7014 1.00 2802 146 0.1539 0.1599 REMARK 3 10 1.7014 - 1.6427 1.00 2819 138 0.1577 0.1804 REMARK 3 11 1.6427 - 1.5913 1.00 2821 149 0.1549 0.1735 REMARK 3 12 1.5913 - 1.5458 1.00 2788 174 0.1665 0.1953 REMARK 3 13 1.5458 - 1.5051 0.99 2801 146 0.1677 0.1852 REMARK 3 14 1.5051 - 1.4684 0.99 2767 162 0.1792 0.2015 REMARK 3 15 1.4684 - 1.4350 0.99 2798 159 0.2008 0.2295 REMARK 3 16 1.4350 - 1.4045 0.98 2762 142 0.2216 0.2749 REMARK 3 17 1.4045 - 1.3764 0.96 2711 124 0.2454 0.2747 REMARK 3 18 1.3764 - 1.3504 0.83 2321 115 0.2968 0.3129 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.140 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 16.220 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.63 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2184 REMARK 3 ANGLE : 1.111 2968 REMARK 3 CHIRALITY : 0.080 301 REMARK 3 PLANARITY : 0.007 383 REMARK 3 DIHEDRAL : 15.854 790 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 11.9037 -1.8387 15.7850 REMARK 3 T TENSOR REMARK 3 T11: 0.0245 T22: 0.0220 REMARK 3 T33: 0.0257 T12: -0.0016 REMARK 3 T13: -0.0000 T23: 0.0003 REMARK 3 L TENSOR REMARK 3 L11: 0.2499 L22: 0.1569 REMARK 3 L33: 0.2221 L12: -0.0768 REMARK 3 L13: -0.0005 L23: -0.0507 REMARK 3 S TENSOR REMARK 3 S11: -0.0059 S12: -0.0165 S13: 0.0116 REMARK 3 S21: -0.0182 S22: 0.0072 S23: 0.0006 REMARK 3 S31: 0.0115 S32: 0.0065 S33: 0.0000 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6VJ3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JAN-20. REMARK 100 THE DEPOSITION ID IS D_1000246479. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-DEC-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : F1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.32 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52776 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.350 REMARK 200 RESOLUTION RANGE LOW (A) : 32.150 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.2 REMARK 200 DATA REDUNDANCY IN SHELL : 1.80 REMARK 200 R MERGE FOR SHELL (I) : 0.52900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 3KS3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.6 M NACITRATE, 50 MM TRIS, PH 7.8, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 20.69950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 27 55.34 -144.55 REMARK 500 ALA A 65 -169.98 -162.95 REMARK 500 PHE A 176 69.79 -153.30 REMARK 500 ASN A 244 47.42 -94.68 REMARK 500 LYS A 252 -138.15 56.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 94 NE2 REMARK 620 2 HIS A 96 NE2 104.4 REMARK 620 3 HIS A 119 ND1 113.1 99.1 REMARK 620 4 QYA A 302 N22 111.5 112.6 115.0 REMARK 620 5 QYA A 302 N22 111.6 113.4 114.3 0.9 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue QYA A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 303 DBREF 6VJ3 A 3 261 UNP P00918 CAH2_HUMAN 3 260 SEQRES 1 A 258 HIS HIS TRP GLY TYR GLY LYS HIS ASN GLY PRO GLU HIS SEQRES 2 A 258 TRP HIS LYS ASP PHE PRO ILE ALA LYS GLY GLU ARG GLN SEQRES 3 A 258 SER PRO VAL ASP ILE ASP THR HIS THR ALA LYS TYR ASP SEQRES 4 A 258 PRO SER LEU LYS PRO LEU SER VAL SER TYR ASP GLN ALA SEQRES 5 A 258 THR SER LEU ARG ILE LEU ASN ASN GLY HIS ALA PHE ASN SEQRES 6 A 258 VAL GLU PHE ASP ASP SER GLN ASP LYS ALA VAL LEU LYS SEQRES 7 A 258 GLY GLY PRO LEU ASP GLY THR TYR ARG LEU ILE GLN PHE SEQRES 8 A 258 HIS PHE HIS TRP GLY SER LEU ASP GLY GLN GLY SER GLU SEQRES 9 A 258 HIS THR VAL ASP LYS LYS LYS TYR ALA ALA GLU LEU HIS SEQRES 10 A 258 LEU VAL HIS TRP ASN THR LYS TYR GLY ASP PHE GLY LYS SEQRES 11 A 258 ALA VAL GLN GLN PRO ASP GLY LEU ALA VAL LEU GLY ILE SEQRES 12 A 258 PHE LEU LYS VAL GLY SER ALA LYS PRO GLY LEU GLN LYS SEQRES 13 A 258 VAL VAL ASP VAL LEU ASP SER ILE LYS THR LYS GLY LYS SEQRES 14 A 258 SER ALA ASP PHE THR ASN PHE ASP PRO ARG GLY LEU LEU SEQRES 15 A 258 PRO GLU SER LEU ASP TYR TRP THR TYR PRO GLY SER LEU SEQRES 16 A 258 THR THR PRO PRO LEU LEU GLU CYS VAL THR TRP ILE VAL SEQRES 17 A 258 LEU LYS GLU PRO ILE SER VAL SER SER GLU GLN VAL LEU SEQRES 18 A 258 LYS PHE ARG LYS LEU ASN PHE ASN GLY GLU GLY GLU PRO SEQRES 19 A 258 GLU GLU LEU MET VAL ASP ASN TRP ARG PRO ALA GLN PRO SEQRES 20 A 258 LEU LYS ASN ARG GLN ILE LYS ALA SER PHE LYS HET ZN A 301 1 HET QYA A 302 66 HET GOL A 303 14 HETNAM ZN ZINC ION HETNAM QYA 2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-N-(4- HETNAM 2 QYA SULFAMOYLPHENYL)ACETAMIDE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 ZN ZN 2+ FORMUL 3 QYA C12 H12 N4 O5 S FORMUL 4 GOL C3 H8 O3 FORMUL 5 HOH *245(H2 O) HELIX 1 AA1 GLY A 12 ASP A 19 5 8 HELIX 2 AA2 PHE A 20 GLY A 25 5 6 HELIX 3 AA3 LYS A 127 GLY A 129 5 3 HELIX 4 AA4 ASP A 130 VAL A 135 1 6 HELIX 5 AA5 LYS A 154 GLY A 156 5 3 HELIX 6 AA6 LEU A 157 LEU A 164 1 8 HELIX 7 AA7 ASP A 165 LYS A 168 5 4 HELIX 8 AA8 ASP A 180 LEU A 185 5 6 HELIX 9 AA9 SER A 219 ARG A 227 1 9 SHEET 1 AA1 2 ASP A 32 ILE A 33 0 SHEET 2 AA1 2 THR A 108 VAL A 109 1 O THR A 108 N ILE A 33 SHEET 1 AA210 LYS A 39 TYR A 40 0 SHEET 2 AA210 LYS A 257 ALA A 258 1 O ALA A 258 N LYS A 39 SHEET 3 AA210 TYR A 191 GLY A 196 -1 N THR A 193 O LYS A 257 SHEET 4 AA210 VAL A 207 LEU A 212 -1 O VAL A 207 N GLY A 196 SHEET 5 AA210 LEU A 141 VAL A 150 1 N GLY A 145 O ILE A 210 SHEET 6 AA210 ALA A 116 ASN A 124 -1 N LEU A 118 O ILE A 146 SHEET 7 AA210 TYR A 88 TRP A 97 -1 N HIS A 94 O HIS A 119 SHEET 8 AA210 PHE A 66 PHE A 70 -1 N VAL A 68 O PHE A 93 SHEET 9 AA210 SER A 56 ASN A 61 -1 N LEU A 57 O GLU A 69 SHEET 10 AA210 SER A 173 ASP A 175 -1 O ALA A 174 N ILE A 59 SHEET 1 AA3 6 LEU A 47 SER A 50 0 SHEET 2 AA3 6 VAL A 78 GLY A 81 -1 O LYS A 80 N SER A 48 SHEET 3 AA3 6 TYR A 88 TRP A 97 -1 O TYR A 88 N LEU A 79 SHEET 4 AA3 6 ALA A 116 ASN A 124 -1 O HIS A 119 N HIS A 94 SHEET 5 AA3 6 LEU A 141 VAL A 150 -1 O ILE A 146 N LEU A 118 SHEET 6 AA3 6 ILE A 216 VAL A 218 1 O ILE A 216 N PHE A 147 LINK NE2 HIS A 94 ZN ZN A 301 1555 1555 2.02 LINK NE2 HIS A 96 ZN ZN A 301 1555 1555 2.04 LINK ND1 HIS A 119 ZN ZN A 301 1555 1555 2.08 LINK ZN ZN A 301 N22AQYA A 302 1555 1555 1.93 LINK ZN ZN A 301 N22BQYA A 302 1555 1555 1.95 CISPEP 1 SER A 29 PRO A 30 0 -2.31 CISPEP 2 PRO A 201 PRO A 202 0 12.41 SITE 1 AC1 4 HIS A 94 HIS A 96 HIS A 119 QYA A 302 SITE 1 AC2 19 ASN A 67 ILE A 91 GLN A 92 HIS A 94 SITE 2 AC2 19 HIS A 96 HIS A 119 PHE A 131 GLY A 132 SITE 3 AC2 19 LEU A 198 THR A 199 THR A 200 TRP A 209 SITE 4 AC2 19 ZN A 301 GOL A 303 HOH A 401 HOH A 403 SITE 5 AC2 19 HOH A 411 HOH A 439 HOH A 566 SITE 1 AC3 11 ASN A 62 HIS A 64 ALA A 65 ASN A 67 SITE 2 AC3 11 GLN A 92 HIS A 94 THR A 200 QYA A 302 SITE 3 AC3 11 HOH A 439 HOH A 471 HOH A 474 CRYST1 42.524 41.399 72.158 90.00 104.44 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023516 0.000000 0.006054 0.00000 SCALE2 0.000000 0.024155 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014310 0.00000